In Silico Drug Repurposing of Penicillins to Target Main Protease M^proof SARS-CoV-2

Baby Krishnaprasad ¹ , Swastika Maity ¹ , Chetan Mehta ² , Akhil Suresh ² , Usha Y Nayak ² , Yogendra Nayak ¹ *

Cited by CrossRef: 3

1- Velagacherla V, Suresh A, Mehta C, Nayak U, Nayak Y. Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment. Viruses. 2023;15(1):213 [Crossref]

2- Fadlalla M, Ahmed M, Ali M, Elshiekh A, Yousef B. Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models. Curr Pharmacol Rep. 2022;8(3):212 [Crossref]

3- Baby K, Maity S, Mehta C, Nayak U, Shenoy G, Pai K, Harikumar K, Nayak Y. Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer. Sci Rep. 2023;13(1) [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE

Research Article

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2

Cited by CrossRef: 3

In Silico Drug Repurposing of Penicillins to Target Main Protease M^proof SARS-CoV-2